34 citations as recorded by crossref.

1. Gentamicin and clindamycin antibiotic-eluting depot technology eradicates S. aureus in an implant-associated osteomyelitis pig model without systemic antibiotics N. Henriksen et al. 10.1128/aac.00691-24
2. One-stage exchange should be avoided in periprosthetic joint infection cases with massive femoral bone loss or with history of any failed revision to treat periprosthetic joint infection P. Slullitel et al. 10.1302/0301-620X.103B7.BJJ-2020-2155.R1
3. Improving outcomes in acute and chronic periprosthetic hip and knee joint infection with a multidisciplinary approach M. Biddle et al. 10.1302/2633-1462.27.BJO-2021-0064.R1
4. Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip J. Conway et al. 10.1128/aac.00655-24
5. Differences in Success Rate of Two-Stage Revision for Periprosthetic Joint Infection of the Knee Depending on the Applied Definition A. Lunz et al. 10.1016/j.arth.2024.09.007
6. Strategisches Vorgehen bei chronischen Infektionen von Endoprothesen P. Savov et al. 10.1007/s00113-021-01113-4
7. Impact of Positive Cultures During the Second Stage of a Two-Stage Exchange: Systematic Review and Meta-Analysis M. Sabater-Martos et al. 10.1016/j.arth.2023.09.022
8. Application of structural allogenous bone graft in two-stage exchange arthroplasty for knee periprosthetic joint infection: a case control study C. Chuang et al. 10.1186/s12891-022-05228-6
9. Plasma fibrinogen: a sensitive biomarker for the screening of periprosthetic joint infection in patients undergoing re-revision arthroplasty H. Xu et al. 10.1186/s12891-022-05476-6
10. Predictors of outcome following two-stage revision total knee arthroplasty A. Rajgopal et al. 10.1007/s00402-024-05580-3
11. Recent Advances in the Evaluation of Antimicrobial Materials for Resolution of Orthopedic Implant-Associated Infections In Vivo E. Cyphert et al. 10.1021/acsinfecdis.1c00465
12. Prevalence, interpretation, and management of unexpected positive cultures in revision TKA: a systematic review J. Kloos et al. 10.1007/s00167-021-06856-6
13. Clinical impact of microbiological results in two-stage revision arthroplasty with spacer exchange B. Frank et al. 10.1007/s00402-023-04770-9
14. Survival and Outcomes of 1.5-Stage vs 2-Stage Exchange Total Knee Arthroplasty Following Prosthetic Joint Infection A. Nabet et al. 10.1016/j.arth.2022.01.043
15. Cement Loaded With High-Dose Gentamicin and Clindamycin Reduces the Risk of Subsequent Infection After One-Stage Hip or Knee Arthroplasty Exchange for Periprosthetic Infection: A Preliminary Study J. Jenny et al. 10.1016/j.arth.2021.08.014
16. Detailed Revision Risk Analysis after Single- vs. Two-Stage Revision Total Knee Arthroplasty in Periprosthetic Joint Infection: A Retrospective Tertiary Center Analysis L. Tuecking et al. 10.3390/antibiotics10101177
17. In Vitro Characterization of Hydroxyapatite-Based Coatings Doped with Mg or Zn Electrochemically Deposited on Nanostructured Titanium D. Vranceanu et al. 10.3390/biomimetics9040244
18. Management strategies for prosthetic joint infection: long-term infection control rates, overall survival rates, functional and quality of life outcomes T. Karachalios & G. Komnos 10.1302/2058-5241.6.210008
19. Unexpected positive culture (UPC) in adults revision spine surgery: a systematic review and meta-analysis of incidence, risk factors, and management P. Mirghaderi et al. 10.1007/s00586-024-08229-2
20. Risk of Infection After Septic and Aseptic Revision Total Knee Arthroplasty C. Lee et al. 10.2106/JBJS.23.00361
21. Novel, static, permanent spacers to treat chronic knee periprosthetic joint infections S. Li et al. 10.1007/s00264-023-05884-w
22. Outcomes after antibiotic megaspacer implantation in patients with severe chronic periprosthetic infections S. Amin et al. 10.1002/jor.24911
23. Current Concepts on the Clinical and Economic Impact of Periprosthetic Joint Infections S. Sadhwani et al. 10.1016/j.ocl.2023.09.001
24. Early-Outcome Differences between Acute and Chronic Periprosthetic Joint Infections—A Retrospective Single-Center Study Y. Youssef et al. 10.3390/antibiotics13030198
25. FeMn and FeMnAg biodegradable alloys: An in vitro and in vivo investigation L. Saliba et al. 10.1016/j.heliyon.2023.e15671
26. Repeat revision TKR for failed management of peri-prosthetic infection has long-term success but often require multiple operations: a case control study H. Rajgor et al. 10.1007/s00402-022-04594-z
27. Tibial Tubercle Osteotomy in Revision Total Knee Arthroplasty for Periprosthetic Infection N. Cance et al. 10.2106/JBJS.23.00256
28. Which Combination is the Best? A Comparison of the Predictive Potential of Serum Biomarker Combinations to Diagnose Periprosthetic Joint Infection J. Yu et al. 10.1016/j.arth.2023.05.025
29. Failed 2-Stage Revision Knee Arthroplasty for Periprosthetic Joint Infection—Patient Characteristics and Outcomes I. Shichman et al. 10.1016/j.arth.2023.04.063
30. Debridement, Antibiotics and Implant Retention: A Systematic Review of Strategies for Treatment of Early Infections after Revision Total Knee Arthroplasty C. Hulleman et al. 10.3390/jcm12155026
31. Single-stage revision for the infected total knee arthroplasty N. Razii et al. 10.1302/2633-1462.25.BJO-2020-0185.R1
32. Change in organism between first- and second-stage revision for periprosthetic joint infection of knee arthroplasty independently associated with increased risk of failure L. Walker et al. 10.1302/2633-1462.49.BJO-2023-0067.R1
33. Development of systemic immune dysregulation in a rat trauma model of biomaterial-associated infection C. Vantucci et al. 10.1016/j.biomaterials.2020.120405
34. Comparable clinical outcomes of culture-negative and culture-positive periprosthetic joint infections: a systematic review and meta-analysis F. Li et al. 10.1186/s13018-023-03692-x